Systemic therapeutic strategies for prostate cancer.
Nelson
William G
WG
Johns Hopkins Medical Institute, Baltimore, MD 21205, USA.
D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy*; D019496:Cancer Vaccines / Q000627:therapeutic use; D002369:Castration; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000639:trends; D009362:Neoplasm Metastasis / Q000517:prevention & control; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000628:therapy*
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D017430:Prostate-Specific Antigen